Strengthening evidence generation in the EU

• Date:
  Tuesday, 10 June 2025, 14:00 - 15:00 Amsterdam time (CEST)
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands
  Live broadcast

Event summary

High-quality clinical evidence is at the heart of well-informed decisions on medicines.

Join us for a live discussion on how to strengthen evidence generation in Europe’s quickly evolving healthcare landscape.

Our vision is that by 2030, clinical evidence generation will be further guided by the patient voice and informed by existing data and knowledge; study design will be driven by the research questions to be addressed; clinical trials will be more efficient and impactful; real-world evidence (RWE) will be enabled and its value established; and trust will be built through transparency.

During the session, our speakers will explore these guiding principles and how stakeholders can apply them for excellent clinical evidence.

Speakers:
• Peter Arlett, Head of Data Analytics and Methods Task Force, European Medicines Agency (EMA)
• María Jesús Lamas Díaz, Chair of Heads of Medicines Agencies' (HMA) Management Group
• Moderator: Alessandro Faia, EMA’s communication department

The event is organised by EMA and the HMA.

LinkedIn Live

Follow the discussion on EMA's LinkedIn.

We welcome your questions. You can post them in the comment section, before or during the event.